应用离子导入治疗眼底出血的临床分析

Clinical Analysis on Subhyaloid Hemorrhage of Treatment with Iontophoresis

目的观察应用玻璃酸酶及碘化钾离子导入治疗眼底出血的临床疗效。方法选择眼底出血病人90例,分为碘化钾合并玻璃酸酶组、碘化钾组和对照组,共同给予血管扩张药物治疗,治疗组分别予相应药物离子导入治疗,并比较3组的疗效。结果碘化钾合并玻璃酸酶组有效率90%,碘化钾组83.3%,明显高于对照组(P<0.05),碘化钾合并玻璃酸酶组疗效略高于碘化钾组,但无统计学差异。结论应用碘化钾合并玻璃酸酶或单独应用碘化钾离子导入治疗眼底出血,治疗效果良好,可作为眼底出血的一种辅助治疗手段。

Objective To observe the iontophoresis of hyalase and KI in treatment of subhyaloid hemorrhage. Methods 90 cases of such patient were chosen and divided into KI and hyalase group, KI group and control group. Three group were treated with vessel dilated drugs and iontophoresis relative drug. The effect was compared after treatment. Results The effective rate was 90% in KI and hyalase group and 83.3% （without difference between them） in KI group that higher than that in control group. Condusion Both KI and Hyalase and KI groups might have obtained good effect to treat the subhyaloid hemorrhage.